Attached files

file filename
EX-31.1 - AMEXDRUG CORPamexdrug10kexh311.txt
EX-31.2 - AMEXDRUG CORPamexdrug10kexh312.txt
EX-10.10 - AMEXDRUG CORPamexdrug10k20101231ex10-10.htm
EX-10.9 - AMEXDRUG CORPamexdrug10k20101231ex10-09.htm
EX-10.12 - AMEXDRUG CORPamexdrug10k20101231ex10-12.htm
EX-10.11 - AMEXDRUG CORPamexdrug10k20101231ex10-11.htm
EX-32.2 - AMEXDRUG CORPamexdrug10kexh322.txt
10-K - AMEXDRUG CORPamexdrug10k.txt

================================================================================

                                  EXHIBIT 32.1

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the Annual Report of Amexdrug Corporation (the
"Company") on Form 10-K for the period ending December 31, 2010, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Jack Amin, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:

      (1)   the Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   the information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.


/s/ Jack Amin
-------------
Jack Amin
Chief Executive Officer
March 31, 2011


-------------------------------------------------------------------------------